Oct 26, 2016 8:00 am EDT Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre
Jul 15, 2016 12:24 pm EDT Acasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM
Mar 25, 2016 2:02 pm EDT Nasdaq Grants Acasti Cure Period to Regain Compliance with Audit Committee Membership Requirements
Mar 1, 2016 8:00 am EST Acasti Announces Management Appointment and Changes to the Board of Directors